Skip to content

GeneDx Holdings Corp.

Public company

As of Nov 18, 2026, the newest executive change on record for GeneDx Holdings Corp. is the appointment of Everett Cunningham as CEO, in an SEC 8-K filed Nov 18, 2026.Updated

Headquarters
STAMFORD, Connecticut
Ticker
WGS
CIK
0001818331

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

1
1 appointment, 0 departures

Last event

Nov 18, 2026
Executive appointmentCEO appointed: Everett Cunningham

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CEOEverett CunninghamNov 18, 2026Appointed

Same industry, the same state first.

  1. Executive appointment

    CEO appointed: Everett Cunningham

    Everett Cunningham was named CEO of GeneDx Holdings Corp.. Everett Cunningham succeeds Katherine Stueland. The company reported the change in an 8-K that cites Item 5.02.

    Role: CEO

Only one public record so far. We add events as soon as a new filing lands; watch GeneDx Holdings Corp. to get them in your digest.

Last verified Nov 18, 2026

Methodology

Questions about GeneDx Holdings Corp.

Who is the new CEO of GeneDx Holdings Corp.?
Everett Cunningham was appointed CEO of GeneDx Holdings Corp., reported in an SEC 8-K filed Nov 18, 2026. It is the newest executive change on record for GeneDx Holdings Corp. as of Nov 18, 2026.The SEC 8-K filingAll leadership changes